GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/PFAS, Pesticides and IBD
91

PFAS, Pesticides and IBD

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated August 1, 2025

Per- and polyfluoroalkyl substances (PFAS) and agricultural pesticides are increasingly recognized as environmental factors that contribute to the risk of inflammatory bowel diseases (IBD), particularly Crohn's disease. Here’s a detailed breakdown of their roles and mechanisms:

PFAS and Crohn’s Disease:

PFAS, often called "forever chemicals," are synthetic compounds widely used in consumer products such as food packaging, nonstick cookware, waterproof textiles, and other household items. These chemicals are highly persistent in the environment and accumulate in human tissues over time, posing significant health risks.

Evidence Linking PFAS to Crohn’s Disease:

  1. Occupational Studies: Early data from occupational cohorts, such as those involving workers at DuPont, initially highlighted the association between PFAS exposure and IBD.

  2. Military-Recruit Sera Studies: Longitudinal studies on military recruits showed that higher levels of PFAS mixtures in blood were associated with increased odds of developing Crohn’s disease, even years before diagnosis. This association was observed across multiple pre-diagnosis timepoints.

  3. Early-Life Exposure: Research on newborn dried blood spots revealed that higher PFAS levels correlated with elevated fecal calprotectin, a marker of intestinal inflammation. This suggests that PFAS exposure early in life may predispose individuals to Crohn’s disease later.

Mechanisms of Action:

PFAS contribute to Crohn’s disease through biologically plausible mechanisms:

  • Impairment of Intestinal Barrier Integrity: PFAS disrupt the epithelial barrier in the gut, allowing harmful substances to penetrate and trigger inflammation.
  • Alteration of IgG Glycosylation: PFAS affect immune system function by altering IgG glycosylation, which may promote mucosal inflammation and immune dysregulation.

Pesticides and Crohn’s Disease:

Agricultural pesticides, particularly those used in intensively farmed regions, have also been implicated in Crohn’s disease pathogenesis. Rural areas with high pesticide use have shown clusters of Crohn’s disease cases.

Evidence Linking Pesticides to Crohn’s Disease:

  1. Geographical Clustering: Regions like Northern France and Denmark have reported higher Crohn’s disease incidence in areas with intensive farming. Danish nationwide data demonstrated a dose-dependent risk of Crohn’s disease associated with early-life exposure to agricultural land use.

  2. Timing of Exposure: High pesticide exposure 6–10 years before Crohn’s disease onset was associated with increased risk, indicating a latency period between exposure and disease development.

  3. Specific Chemicals: Studies have identified certain biocides, such as the herbicide propyzamide, as particularly problematic. Propyzamide has been shown to directly disrupt epithelial barriers in the gut.

Mechanisms of Action:

Pesticides contribute to Crohn’s disease through:

  • Disruption of Epithelial Barriers: Similar to PFAS, pesticides can impair the gut’s protective barrier, making it more susceptible to inflammation.
  • Environmental Impact: Agricultural chemicals may alter the microbiome or introduce toxins that exacerbate intestinal inflammation and immune system dysregulation.

Combined Impact of PFAS and Pesticides:

Both PFAS and pesticides are modifiable environmental factors that increase the risk of Crohn’s disease. Their combined impact is particularly concerning in rural and agricultural settings where exposure to both streams is likely.

Implications for Public Health and Clinical Practice:

  1. Exposure Assessment: Clinical histories should include detailed exposure assessments for PFAS and pesticides, especially for patients with suspected or diagnosed Crohn’s disease.

  2. Preventive Measures: Public health actions should aim to reduce contact with these chemicals across the life course. This includes stricter regulations on PFAS use and agricultural pesticide application.

  3. Research and Advocacy: Further research is needed to refine our understanding of how these chemicals interact with genetic and environmental factors in Crohn’s disease pathogenesis. Advocacy for safer chemical alternatives and improved environmental policies is critical.

Conclusion:

The evidence strongly supports PFAS and pesticides as modifiable contributors to Crohn’s disease, emphasizing the importance of reducing exposure to these chemicals to mitigate risk. Their role in disrupting gut barrier integrity and immune function provides a mechanistic link to the inflammation characteristic of Crohn’s disease, underscoring the need for both clinical vigilance and public health interventions.

Related Q&A

92

Obesity and response to IBD treatment

Obesity has been identified as a significant factor influencing the response to treatment in patients with inflammatory bowel disease (IBD). A large registry-based study from the Initiative on...

93

Hypogonadism and Bone Health in IBD

Hypogonadism and Bone Health in IBD (Inflammatory Bowel Disease) Hypogonadism is a common complication in patients with IBD, and it has significant implications for bone health. The interplay...

94

Ultraprocessed Food and Premature Death

Ultraprocessed foods (UPFs) have been linked to higher rates of premature death, according to a global analysis conducted across eight countries. The study highlights a clear dose–response pattern:...

95

Obesity and Gut Microbiota

Obesity and gut microbiota are intricately linked, as the microbial composition and functions in the gut play a significant role in energy balance, metabolism, and fat storage. The...

96

DGBI and Carbohydrate intolerance

Disorders of Gut-Brain Interaction (DGBI) and Carbohydrate Intolerance: Overview of DGBI: Disorders of Gut-Brain Interaction (DGBI) encompass a group of conditions characterized by abnormal communication between the gut...

97

Auto-Brewery Syndrome (ABS)

Auto-Brewery Syndrome (ABS), also referred to as gut fermentation syndrome, is a rare and likely underdiagnosed medical condition in which gut microbes (bacteria and/or yeast) ferment carbohydrates into...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer